| 000 | 01800 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516163440.0 | ||
| 264 | 0 | _c20130815 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMoa1213299 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVander Lugt, Mark T | |
| 245 | 0 | 0 |
_aST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cAug 2013 |
||
| 300 |
_a529-39 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xblood |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterleukin-1 Receptor-Like 1 Protein |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xblood |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aBraun, Thomas M | |
| 700 | 1 | _aHanash, Samir | |
| 700 | 1 | _aRitz, Jerome | |
| 700 | 1 | _aHo, Vincent T | |
| 700 | 1 | _aAntin, Joseph H | |
| 700 | 1 | _aZhang, Qing | |
| 700 | 1 | _aWong, Chee-Hong | |
| 700 | 1 | _aWang, Hong | |
| 700 | 1 | _aChin, Alice | |
| 700 | 1 | _aGomez, Aurélie | |
| 700 | 1 | _aHarris, Andrew C | |
| 700 | 1 | _aLevine, John E | |
| 700 | 1 | _aChoi, Sung W | |
| 700 | 1 | _aCouriel, Daniel | |
| 700 | 1 | _aReddy, Pavan | |
| 700 | 1 | _aFerrara, James L M | |
| 700 | 1 | _aPaczesny, Sophie | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 369 _gno. 6 _gp. 529-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa1213299 _zAvailable from publisher's website |
| 999 |
_c22983928 _d22983928 |
||